Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6895207

CC(C)C1=Cc2c(ccc3ccccc23)C1[Zr+2]1(C2C(C(C)C)=Cc3c2ccc2ccccc32)CCC1.[Cl-].[Cl-]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 1/20 0.30
SLC6A3 known ✓ Q01959 1/20 0.30
KDM4E B2RXH2 1/20 0.34
SLC18A2 Q05940 1/20 0.32
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6886402 0.95 KDM4E (0.36) KDM4ESLC18A2SLC6A4
Hydrochloric Acid SCHEMBL6884761 0.88 NPC1 (0.33)
Hydrochloric Acid SCHEMBL6892170 0.83 KDM4E (0.34) KDM4ESLC18A2
Hydrochloric Acid SCHEMBL5068152 0.82 KDM4E (0.36) KDM4ESLC18A2SLC6A4
Hydrochloric Acid SCHEMBL6891304 0.82 HTR1A (0.35)
Hydrochloric Acid SCHEMBL6891796 0.82 NPC1 (0.34) SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL6886390 0.81 KDM4E (0.35) KDM4ESLC18A2
Hydrochloric Acid SCHEMBL673327 0.80 KDM4E (0.36) KDM4ESLC18A2SLC6A4
Hydrochloric Acid SCHEMBL6891775 0.79 KDM4E (0.34) KDM4E
Hydrochloric Acid SCHEMBL6893714 0.79 KDM4E (0.39) KDM4ESLC18A2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6784305-B2 DERIVATIVES OF ZIRCONOCENE DICHLORIDE IN WHICH THE TWO SUBSTITUTED INDENYL GROUPS ARE JOINED TO ONE ANOTHER VIA A BRIDGE CAN, OWING TO THEIR CONFORMATIONAL RIGIDITY, BE USED AS CATALYSTS FOR THE STEREOSPECIFIC POLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2004-08-31 US disclosed
US-20030199703-A1 Method for producing alkyl-bridged ligand systems and transition metal compounds EQUISTAR CHEMICALS, LP 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199703-A1 Method for producing alkyl-bridged ligand systems and transition metal compounds ABL1, ICMT, ORAI2 SLC6A2 2028/4885SLC6A3 1338/4885KDM4E 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.